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Metallo--lactamase enzymes (ML) are encoded by transferable genes, which appear to spread rapidly
among gram-negative bacteria. The objective of this study was to develop a multiplex real-time PCR assay
followed by a melt curve step for rapid detection and identification of genes encoding ML-type enzymes based
on the amplicon melting peak. The reference sequences of all genes encoding IMP and VIM types, SPM-1,
GIM-1, and SIM-1 were downloaded from GenBank, and primers were designed to obtain amplicons showing
different sizes and melting peak temperatures (Tm). The real-time PCR assay was able to detect all ML-
harboring clinical isolates, and the Tm-assigned genotypes were 100% coincident with previous sequencing
results. This assay could be suitable for identification of ML-producing gram-negative bacteria by molecular
diagnostic laboratories.
Since the first report of acquired metallo--lactamase
(ML) in Japan in 1994 (15), genes encoding IMP- and VIM-
type enzymes have spread rapidly among Pseudomonas spp. (1,
5, 10, 13, 14, 16, 18, 22–24), Acinetobacter spp. (3, 4, 17, 21, 29),
and strains of Enterobacteriaceae (6, 8, 11, 12, 20, 28). More-
over, new ML types have been described, such as SPM (25),
GIM (2), and, more recently, SIM (9).
The prevalence of ML-producing gram-negative bacilli has
increased in some hospitals, particularly among clinical isolates of
Pseudomonas aeruginosa and Acinetobacter spp. (21, 23, 27). Since
ML production may confer phenotypic resistance to virtually all
clinically available -lactams, the continued spread of ML is a
major clinical concern (26). The aim of this study was to develop
a multiplex real-time PCR assay followed by a melt curve step for
rapid detection and identification of genes encoding the ML-
type enzymes so far described. The ML type identification was
based on the characteristic amplicon melting peak.
MATERIALS AND METHODS
ML-harboring clinical isolates and ML-negative control strains. The
strains used in this study are listed in Tables 1 and 2. The ML genotypes of the
clinical isolates of gram-negative nonfermentative and fermentative bacteria
harboring ML were previously characterized by PCR and sequencing. When
applicable, these clinical isolates were also previously molecularly typed to en-
sure that genetically unrelated strains were used. Additionally, several American
Type Culture Collection (ATCC; Manassas, VA) reference strains and labora-
tory strains were used as ML-negative controls (Table 2).
DNA preparation. The microorganisms were grown on blood agar plates
overnight at 37°C to ensure colony purity. Three or four bacterial colonies were
taken from the blood agar plates and suspended in 200 l of DNase/RNase-free
distilled water (Invitrogen, CA). Two microliters of this suspension was used as
templates for further amplification.
Primer design. The currently available reference sequences of the ML-encoding
IMP- and VIM-type (http://www.lahey.org/studies/), SPM-1 (AJ492820), GIM-1
(AJ620678), and SIM-1 (AY887066) genes were downloaded from GenBank (Na-
tional Center for Biotechnology Information, National Institutes of Health, Be-
thesda, MD). Based on the comprehensive analyses and alignments of each
ML type, primers were designed to yield amplicons showing different sizes
and melting peak temperatures (Tm) separated by at least 1°C. Predicted
amplicon sizes and Tm were determined by the Lasergene software package
(DNASTAR, Madison, WI).
Additionally, a primer pair targeting the consensus region of the bacterial 16S
rRNA gene was included in the reaction mixture as a PCR internal-control
target. Primer pairs were evaluated in a single format (using a primer concen-
tration of 0.5 M) to ensure that they correctly amplified their respective loci and
that the amplicons showed the expected Tm. Subsequently, the multiplex format
was optimized by assaying different primer pair concentrations. The primer
sequences, positions, and concentrations, and the sizes of the corresponding
amplicons, are given in Table 3.
Multiplex real-time PCR. Amplification was performed in a 48-l mixture
containing 25 l of Platinum SYBR Green qPCR SuperMix (Platinum Taq DNA
polymerase, SYBR Green I dye, Tris-HCl, KCl, 6 mM MgCl2, 400 M dGTP,
400 M dATP, 400 M dCTP, 800 M dUTP, uracil DNA glycosylase, and
stabilizers) (Invitrogen, CA), six pairs of primers at their respective concentra-
tions (Table 3), and 2 l of the template by using the DNA Engine Opticon 2
system (Bio-Rad Laboratories, CA). The PCR conditions were as follows: initial
denaturation at 94°C for 5 min; 35 cycles of 94°C for 20 s, 53°C for 45 s, and 72°C
for 30 s; and a melt curve step (from 68°C, gradually increasing 0.5°C/s to 95°C,
with acquisition data every 1 s). Melt curves were then converted into melting
peaks by plotting the negative derivative of fluorescence versus temperature
(dF2/dT versus T and dF3/dT versus T).
Multiplex real-time PCR validation. In order to assess the accuracy of the
assay, 44 bacterial strains were blindly tested after real-time PCR optimization
(Tables 1 and 2).
Multiplex real-time PCR sensitivity. The sensitivity of the reaction was esti-
mated by dilution experiments. Briefly, one representative of each ML-harbor-
ing clinical isolate was suspended in DNase/RNase-free distilled water to a
density corresponding to a McFarland turbidity standard of 1.0 (3  108 CFU/
ml). These suspensions were used to prepare serial 10-fold dilutions using
DNase/RNase-free distilled water.
RESULTS AND DISCUSSION
When different strains were submitted to the real-time PCR
assay, differences in the Tm of the amplicons were observed for
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strains harboring blaIMP-type allelic variants (from 76.0°C to
77.5°C) as well as for those harboring blaVIM-type allelic variants
(from 87.5°C to 88.5°C) (Table 1). These differences in Tm will be
observed mainly for amplicons generated from blaIMP-type genes,
since the GC contents of the amplicons generated will be more
divergent than those for blaVIM-type genes (Table 1).
Allelic variants for the remaining ML types (blaSPM-1,
blaGIM-1, and blaSIM-1) have not been found yet. For this rea-
son, only one clinical isolate harboring blaGIM-1 and one har-
boring blaSIM-1 were used during the validation process. The
theoretical and practical Tm obtained were very similar, and no
Tm differences were observed when several genetically unre-
lated blaSPM-1-harboring P. aeruginosa isolates were submitted
to the assay (Table 1).
When the negative-control ATCC reference strains and lab-
oratory strains were submitted to the assay, the melt curve
analysis showed only one melting peak varying from 85.5°C to
86.5°C (Table 2). These melting peaks were consistent with the
Tm of the amplicon generated by the primers targeting the
conserved sequences of the 16S rRNA gene. This internal-
control primer pair was used at a lower concentration than the
primers targeting the ML genes; thus, the latter would have
preference during the amplification reaction. This strategy was
employed to avoid double amplification, which could compro-
mise the melt curve analysis.
The real-time PCR sensitivity experiment showed that the
assay was capable of detecting the16S rRNA target gene at
a dilution corresponding to 6  103 CFU per reaction;
blaSPM, blaVIM, blaSIM, and blaIMP at 6  10
2 CFU per
reaction; and blaGIM at 6  10
1 CFU per reaction (data not
shown). Additionally, the lowest detection limits of the tar-
get genes were represented by the cycle threshold values of
34.62, 34.11, 33.66, 32.69, 32.58, and 28.86 for the16S rRNA,
blaSPM, blaGIM, blaIMP, blaSIM, and blaVIM genes, respec-
tively. This suggests that the assay as developed is suffi-
TABLE 1. ML-harboring clinical isolates used during the validation process
Clinical isolate ML-encodinggene
Reference or
accession no. Strain no. Ribogroup
Tm of amplicon Amplicon GC
content (%)Theoretical Practical
Serratia marcescens blaIMP-1 15 TN9106 NA
a 77.9 77.5 38.30
Pseudomonas putida blaIMP-1 AM283489 48-12346A NA 77.9 77.5 38.30
Enterobacter cloacae blaIMP-1 2a A199 NA 77.9 77.5 38.30
Acinetobacter baumannii blaIMP-1 AJ640197 48-696D NA 77.9 77.5 38.30
P. aeruginosa blaIMP-1 19 A5386 NA 77.9 77.5 38.30
Klebsiella pneumoniae blaIMP-1 11 A13309 NA 77.9 77.5 38.30
P. aeruginosa blaIMP-5 19a 115-10639A NA 77.5 76.5 37.23
P. aeruginosa blaIMP-13 22 86-14571 NA 77.1 76.0 36.17
P. aeruginosa blaIMP-16 14 101-4704 164-7 77.3 76.5 36.70
P. aeruginosa blaIMP-16 This study P3987 164-8 77.3 76.5 36.70
P. aeruginosa blaIMP-18 This study A3486 NA 76.4 76.0 34.57
P. aeruginosa blaVIM-1 23 75-3636C NA 87.1 88.5 57.33
E. cloacae blaVIM-1 AM183120 75-10433A NA 87.1 88.5 57.33
P. aeruginosa blaVIM-2 23 81-11963A NA 86.9 88.0 56.81
P. aeruginosa blaVIM-2 13 49-4583C NA 86.9 88.0 56.81
P. aeruginosa blaVIM-2 This study A1254 NA 86.9 88.0 56.81
P. aeruginosa blaVIM-7 24 7-406 NA 86.2 87.5 55.00
P. aeruginosa blaSPM-1 25 48-1997A 72-3 83.8 83.5 47.62
P. aeruginosa blaSPM-1 7 A3488 88-2 83.8 83.5 47.62
P. aeruginosa blaSPM-1 7 A2535 77-2 83.8 83.5 47.62
P. aeruginosa blaSPM-1 7 A3301 105-3 83.8 83.5 47.62
P. aeruginosa blaSPM-1 7 A3307 106-4 83.8 83.5 47.62
P. aeruginosa blaSPM-1 7 A3302 105-4 83.8 83.5 47.62
P. aeruginosa blaSPM-1 7 A3304 97-7 83.8 83.5 47.62
P. aeruginosa blaSPM-1 7 A3300 105-1 83.8 83.5 47.62
P. aeruginosa blaSPM-1 7 A2839 88-1 83.8 83.5 47.62
P. aeruginosa blaSPM-1 7 A3309 105-5 83.8 83.5 47.62
P. aeruginosa blaSPM-1 7 A2526 78-4 83.8 83.5 47.62
P. aeruginosa blaGIM-1 2 73-5671 NA 72.2 72.0 34.72
A. baumannii blaSIM-1 9 03-9-T104 NA 80.4 80.5 39.89
a NA, not applicable.
TABLE 2. ATCC reference and laboratory strains of gram-negative
bacteria used during the validation process as ML-negative
control strainsa
Organism Strain no. Practicalamplicon Tm
P. aeruginosa PA01 86.0
Escherichia coli DH5 87.0
E. coli DH10B 86.5
E. coli K-12 86.5
E. coli ATCC 25922 85.5
Acinetobacter calcoaceticus ATCC 33305 85.5
Enterobacter aerogenes ATCC 13048 86.5
P. aeruginosa ATCC 27853 86.0
Klebsiella pneumoniae ATCC 700603 86.5
Neisseria meningitidis ATCC 13090 86.0
Neisseria perflava ATCC 14799 86.0
Neisseria lactamica ATCC 49142 86.0
Neisseria sicca ATCC 29193 86.0
Salmonella serovar Typhimurium ATCC 14028 86.0
a The 16S rRNA gene was the target gene in each case.
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ciently robust, even when the bacterial cells suspended in
water are used as the template.
Although the assay was developed to detect all ML-encod-
ing genes, we could not submit strains harboring all the blaIMP
and blaVIM allelic variants, since we do not have access to all of
them. We also acknowledge the possibility of future assay
limitations once more ML types or newly emerging ML
allelic variants are detected, requiring a possible assay recon-
figuration.
The assay was able to detect and identify all ML-harboring
strains evaluated. It is a single-tube reaction, technically sim-
ple, performed in only 2 h after colony selection. The Tm-
assigned ML genotypes are easily interpreted (Fig. 1a) and
may be suitable for the detection of ML-producing gram-
negative bacteria by molecular diagnostic laboratories. Fur-
thermore, the assay may also be performed through a conven-
tional amplification reaction, followed by visualization of the
amplicons by using a UV light box after electrophoresis on
a 1.5% agarose gel containing 0.5 g/ml ethidium bromide
(Fig. 1b).
The rapid detection of ML-producing isolates could be
helpful for epidemiological purposes and for monitoring the
emergence of ML-producing isolates in clinical settings. The
detection of such isolates could help rapidly establish stan-
dards for hospital infection control measures to minimize the
spreading of these resistant determinants.
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